Form 4 holding
Executive VP, Head of R&D
CRISPR Therapeutics AG
- Security class
- Common Shares
- Shares / value
- 52,364
- Estimated value
- $3,272,902
- Report date
- 06 Dec 2021
- Price
- $62.50
- Ownership
- Direct
Tony W. Ho - Executive VP, Head of R&D at CRISPR Therapeutics AG
Issuer-level insider activity
- Role
- Executive VP, Head of R&D
- Issuer ticker
- CRSP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Tony W. Ho since 09 Aug 2025
Reported holdings for Tony W. Ho in CRISPR Therapeutics AG
Form 4 holding
Executive VP, Head of R&D
CRISPR Therapeutics AG
- Security class
- Restricted Stock Units
- Shares / value
- 13,333
- Estimated value
- Report date
- 03 Dec 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Transaction history for Tony W. Ho in CRISPR Therapeutics AG
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.